Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules

The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SI-HONG YUM, PATRICK S L WONG, VU A NGUYEN, PETER E DADDONA, LIANG C DONG, ANTHONY C CHAO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SI-HONG YUM
PATRICK S L WONG
VU A NGUYEN
PETER E DADDONA
LIANG C DONG
ANTHONY C CHAO
description The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as a nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2002359793BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2002359793BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2002359793BB23</originalsourceid><addsrcrecordid>eNqNisEKgkAQhr10iOod5tA1kF0iPGokPUAdQ8Z11IFxR3Y18O0z6AG6_B_fx79NXqWGYRacWD2gb6DRiB1Bu-bvAHsXCCP7DjSgQM2Kb2TBmoWnBbSFfmmCjv3qDgZ0QQcVcrNQ3CebFiXS4cddcixvj-v9RKNWFEd05Gmq8qdJU2PP2SWzRWHsn7cPwz0-dA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules</title><source>esp@cenet</source><creator>SI-HONG YUM ; PATRICK S L WONG ; VU A NGUYEN ; PETER E DADDONA ; LIANG C DONG ; ANTHONY C CHAO</creator><creatorcontrib>SI-HONG YUM ; PATRICK S L WONG ; VU A NGUYEN ; PETER E DADDONA ; LIANG C DONG ; ANTHONY C CHAO</creatorcontrib><description>The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as a nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070614&amp;DB=EPODOC&amp;CC=AU&amp;NR=2002359793B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070614&amp;DB=EPODOC&amp;CC=AU&amp;NR=2002359793B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SI-HONG YUM</creatorcontrib><creatorcontrib>PATRICK S L WONG</creatorcontrib><creatorcontrib>VU A NGUYEN</creatorcontrib><creatorcontrib>PETER E DADDONA</creatorcontrib><creatorcontrib>LIANG C DONG</creatorcontrib><creatorcontrib>ANTHONY C CHAO</creatorcontrib><title>Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules</title><description>The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as a nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNisEKgkAQhr10iOod5tA1kF0iPGokPUAdQ8Z11IFxR3Y18O0z6AG6_B_fx79NXqWGYRacWD2gb6DRiB1Bu-bvAHsXCCP7DjSgQM2Kb2TBmoWnBbSFfmmCjv3qDgZ0QQcVcrNQ3CebFiXS4cddcixvj-v9RKNWFEd05Gmq8qdJU2PP2SWzRWHsn7cPwz0-dA</recordid><startdate>20070614</startdate><enddate>20070614</enddate><creator>SI-HONG YUM</creator><creator>PATRICK S L WONG</creator><creator>VU A NGUYEN</creator><creator>PETER E DADDONA</creator><creator>LIANG C DONG</creator><creator>ANTHONY C CHAO</creator><scope>EVB</scope></search><sort><creationdate>20070614</creationdate><title>Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules</title><author>SI-HONG YUM ; PATRICK S L WONG ; VU A NGUYEN ; PETER E DADDONA ; LIANG C DONG ; ANTHONY C CHAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2002359793BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SI-HONG YUM</creatorcontrib><creatorcontrib>PATRICK S L WONG</creatorcontrib><creatorcontrib>VU A NGUYEN</creatorcontrib><creatorcontrib>PETER E DADDONA</creatorcontrib><creatorcontrib>LIANG C DONG</creatorcontrib><creatorcontrib>ANTHONY C CHAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SI-HONG YUM</au><au>PATRICK S L WONG</au><au>VU A NGUYEN</au><au>PETER E DADDONA</au><au>LIANG C DONG</au><au>ANTHONY C CHAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules</title><date>2007-06-14</date><risdate>2007</risdate><abstract>The present invention includes a formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules. The formulation of the present invention includes a permeation enhancer, a hydrophilic macromolecule, and a carrier that exhibits in-situ gelling properties, such as a nonionic surfactant. The formulation of the present invention is delivered within the GI tract as a liquid having at least some affinity for the surface of the GI mucosal membrane. Once released, it is believed that the liquid formulation spreads across one or more areas of the surface of the GI mucosal membrane, where the carrier of the formulation then transitions into a bioadhesive gel in-situ. As a bioadhesive gel, the formulation of the present invention presents the hydrophilic macromolecule and the permeation enhancer at the surface of the GI mucosal membrane at concentrations sufficient to increase absorption of the hydrophilic macromolecule through the GI mucosal membrane over a period of time. The dosage form of the present invention incorporates the formulation of the present invention and may be designed to provide the controlled release of the formulation within the GI tract over a desired period of time.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2002359793BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T17%3A32%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SI-HONG%20YUM&rft.date=2007-06-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2002359793BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true